The road ahead

The road ahead

Where we are.
What we’re up to.
Where we are.
What we’re up to.

Moving forward

We have an ambitious pipeline that is targeting indications of highest medical need and with a significant market potential.

 


In-vitro PoC
In-vivo PoC
IND-enabling studies
FIH
Oncology
seRNA 001 HCC
Seed Milestones
seRNA 002 Lung cancer
Seed Milestones
seRNA 003 Glioblastoma
Open for partnerships
Non-Oncology
seRNA 004 Viral diseases
Undisclosed
seRNA 005 Autoimmune Diseases
Undisclosed

Interested?

See what’s going on right now!